Evolus Cash from Investing (Quarterly) Analysis

Evolus Inc (EOLS)

13.30 +0.08 (+0.61%) USD | NASDAQ | May 03, 16:00

13.30 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-0.361M
September 30, 2023	-0.539M
June 30, 2023	-0.216M
March 31, 2023	-0.511M
December 31, 2022	-1.391M
September 30, 2022	-0.899M
June 30, 2022	-0.388M
March 31, 2022	-0.261M
December 31, 2021	-0.39M
September 30, 2021	0.021M
June 30, 2021	-0.386M
March 31, 2021	4.785M
December 31, 2020	19.70M

Date	Value
September 30, 2020	29.30M
June 30, 2020	9.38M
March 31, 2020	-46.19M
December 31, 2019	13.97M
September 30, 2019	34.39M
June 30, 2019	8.227M
March 31, 2019	-80.02M
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	-0.009M
March 31, 2018	0.00
December 31, 2017	0.00
September 30, 2017	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-46.19M

Minimum

Mar 2020

34.39M

Maximum

Sep 2019

3.592M

Average

-0.261M

Median

Mar 2022

Cash from Investing (Quarterly) Benchmarks

Viatris Inc	115.80M
Shockwave Medical Inc	-242.26M
Perspective Therapeutics Inc	-0.089M
Electromed Inc	-0.087M
Xtant Medical Holdings Inc	-2.313M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	0.813M
Cash from Financing (Quarterly)	23.52M
Free Cash Flow	-35.64M
Free Cash Flow Per Share (Quarterly)	0.0079
Free Cash Flow to Equity (Quarterly)	-24.81M
Free Cash Flow to Firm (Quarterly)	4.270M
Free Cash Flow Yield	-4.71%